FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2084057573> ?p ?o ?g. }

• W2084057573 endingPage "877" @default.
• W2084057573 startingPage "873" @default.
• W2084057573 abstract "BACKGROUND Sudden hearing loss has been reported on standard interferon (IFN)-α2 therapy. This is the first report on the occurrence of sudden hearing loss in six cases of chronic hepatitis C in temporal relation to treatment with pegylated (PEG)-IFN alfa2a or b/ribavirin combination therapy. Three patients were treated in an ongoing randomized placebo–controlled trial comparing the addition of 200 mg amantadine or placebo to the combination of 180 μg PEG-IFN α2a (PEGASYS®, Roche, Basel, CH)/wk and 1–1.2 g ribavirin/d (COPEGUS®, Roche, Nutley, USA) in de novo patients infected with HCV genotype 1. Sudden hearing loss and tinnitus developed on day 1 and after 4, 23, 25, 36, and 40 wk of treatment, respectively. CONCLUSIONS Sudden hearing loss may occur in about 1% of patients on PEG-IFN/ribavirin combination therapy. This rate was not different to that observed in an untreated population. Possible mechanisms involved include direct ototoxicity of IFN, autoimmunity, and hematological changes. In contrast to published cases on auditory disability due to standard IFN, hearing loss did not fully resolve after discontinuation of therapy with PEG-IFN. On the other hand, symptoms did not worsen on continued treatment. Therefore, the decision whether to continue or to stop the treatment when signs of ototoxicity appear is based on the clinical judgment of the treating physician." @default.
• W2084057573 created "2016-06-24" @default.
• W2084057573 creator A5026730867 @default.
• W2084057573 creator A5030496461 @default.
• W2084057573 creator A5036355580 @default.
• W2084057573 creator A5036880949 @default.
• W2084057573 creator A5038776186 @default.
• W2084057573 creator A5073197069 @default.
• W2084057573 creator A5074942131 @default.
• W2084057573 creator A5090163132 @default.
• W2084057573 date "2004-05-01" @default.
• W2084057573 modified "2023-10-17" @default.
• W2084057573 title "Sudden Hearing Loss in Patients with Chronic Hepatitis C Treated with Pegylated Interferon/Ribavirin" @default.
• W2084057573 cites W1762157941 @default.
• W2084057573 cites W1970882462 @default.
• W2084057573 cites W1971793836 @default.
• W2084057573 cites W1979635840 @default.
• W2084057573 cites W1981195126 @default.
• W2084057573 cites W1985158343 @default.
• W2084057573 cites W1988157743 @default.
• W2084057573 cites W1993979452 @default.
• W2084057573 cites W1997459096 @default.
• W2084057573 cites W2003505350 @default.
• W2084057573 cites W2014515973 @default.
• W2084057573 cites W2035900146 @default.
• W2084057573 cites W2036128957 @default.
• W2084057573 cites W2036587157 @default.
• W2084057573 cites W2038832397 @default.
• W2084057573 cites W2064278664 @default.
• W2084057573 cites W2095004826 @default.
• W2084057573 cites W2114709438 @default.
• W2084057573 cites W2128588668 @default.
• W2084057573 cites W2141249273 @default.
• W2084057573 cites W2141779237 @default.
• W2084057573 cites W2166809504 @default.
• W2084057573 cites W2464181197 @default.
• W2084057573 doi "https://doi.org/10.1111/j.1572-0241.2004.30372.x" @default.
• W2084057573 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15128353" @default.
• W2084057573 hasPublicationYear "2004" @default.
• W2084057573 type Work @default.
• W2084057573 sameAs 2084057573 @default.
• W2084057573 citedByCount "47" @default.
• W2084057573 countsByYear W20840575732012 @default.
• W2084057573 countsByYear W20840575732013 @default.
• W2084057573 countsByYear W20840575732014 @default.
• W2084057573 countsByYear W20840575732015 @default.
• W2084057573 countsByYear W20840575732016 @default.
• W2084057573 countsByYear W20840575732017 @default.
• W2084057573 countsByYear W20840575732018 @default.
• W2084057573 countsByYear W20840575732019 @default.
• W2084057573 countsByYear W20840575732020 @default.
• W2084057573 countsByYear W20840575732021 @default.
• W2084057573 countsByYear W20840575732023 @default.
• W2084057573 crossrefType "journal-article" @default.
• W2084057573 hasAuthorship W2084057573A5026730867 @default.
• W2084057573 hasAuthorship W2084057573A5030496461 @default.
• W2084057573 hasAuthorship W2084057573A5036355580 @default.
• W2084057573 hasAuthorship W2084057573A5036880949 @default.
• W2084057573 hasAuthorship W2084057573A5038776186 @default.
• W2084057573 hasAuthorship W2084057573A5073197069 @default.
• W2084057573 hasAuthorship W2084057573A5074942131 @default.
• W2084057573 hasAuthorship W2084057573A5090163132 @default.
• W2084057573 hasConcept C126322002 @default.
• W2084057573 hasConcept C142724271 @default.
• W2084057573 hasConcept C203014093 @default.
• W2084057573 hasConcept C204787440 @default.
• W2084057573 hasConcept C2522874641 @default.
• W2084057573 hasConcept C27081682 @default.
• W2084057573 hasConcept C2776408679 @default.
• W2084057573 hasConcept C2776455275 @default.
• W2084057573 hasConcept C2776461080 @default.
• W2084057573 hasConcept C2776694085 @default.
• W2084057573 hasConcept C2776992516 @default.
• W2084057573 hasConcept C2778239845 @default.
• W2084057573 hasConcept C2778534666 @default.
• W2084057573 hasConcept C2778715236 @default.
• W2084057573 hasConcept C2780040827 @default.
• W2084057573 hasConcept C2780493683 @default.
• W2084057573 hasConcept C2908647359 @default.
• W2084057573 hasConcept C548259974 @default.
• W2084057573 hasConcept C71924100 @default.
• W2084057573 hasConcept C90924648 @default.
• W2084057573 hasConcept C99454951 @default.
• W2084057573 hasConceptScore W2084057573C126322002 @default.
• W2084057573 hasConceptScore W2084057573C142724271 @default.
• W2084057573 hasConceptScore W2084057573C203014093 @default.
• W2084057573 hasConceptScore W2084057573C204787440 @default.
• W2084057573 hasConceptScore W2084057573C2522874641 @default.
• W2084057573 hasConceptScore W2084057573C27081682 @default.
• W2084057573 hasConceptScore W2084057573C2776408679 @default.
• W2084057573 hasConceptScore W2084057573C2776455275 @default.
• W2084057573 hasConceptScore W2084057573C2776461080 @default.
• W2084057573 hasConceptScore W2084057573C2776694085 @default.
• W2084057573 hasConceptScore W2084057573C2776992516 @default.
• W2084057573 hasConceptScore W2084057573C2778239845 @default.
• W2084057573 hasConceptScore W2084057573C2778534666 @default.
• W2084057573 hasConceptScore W2084057573C2778715236 @default.
• W2084057573 hasConceptScore W2084057573C2780040827 @default.

• next